• The management of Eris Lifesciences Limited will be participating in an investor conference meeting categorized as a 1X1 (one-on-one) interaction.
  • The event is scheduled for Friday, May 29, 2026, at 10:30 AM IST.
  • The meeting will be conducted in virtual mode with Franklin Templeton.
  • Management representation will be led by Mr. Krishnakumar Vaidyanathan.
  • The stated purpose is investor interaction through conference participation.
  • The company explicitly states that no unpublished price sensitive information (UPSI) will be discussed during the interaction.
  • The company will be referring only to publicly available documents for discussions.
  • The schedule is indicative and subject to changes due to unforeseen developments.

Additional Notes Section

  • This is a regulatory disclosure made pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.
  • No financial data, performance figures, guidance, or strategic updates were disclosed in this announcement.
  • The document does not include any attachments such as presentation decks or detailed schedules.